Abstract 3420: Tgfbm3b is a natural germline genetic variant that modifies anti-tumor responses to anti-PD-1 immunotherapy through its action on the tumor microenvironment.

Cancer research

Szu-Ying Chen, Ons Mamai, Rosemary Akhurst. Abstract 3420: Tgfbm3b is a natural germline genetic variant that modifies anti-tumor responses to anti-PD-1 immunotherapy through its action on the tumor microenvironment. Cancer Research. 2022 Jun 15; 82(12_Supplement):3420-3420.

2022

https://researcherprofiles.org/profile/344526856

Szu-Ying Chen, Ons Mamai, Rosemary Akhurst

Women in Science @UCSF

Search form

You are here

Abstract 3420: Tgfbm3b is a natural germline genetic variant that modifies anti-tumor responses to anti-PD-1 immunotherapy through its action on the tumor microenvironment.